Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Assessment of Ozonated Sunflower Seed Oil Gel as an Adjunctive Therapy to Mechanical Debridement in the Treatment of Stage II Grade B Periodontitis

7 de junho de 2026 atualizado por: Ahmed Hashem Ahmed Alshareef, Mansoura University

Assessment of Ozonated Sunflower Seed Oil Gel as an Adjunctive Therapy to Mechanical Debridement in the Treatment of Stage II Grade B Periodontitis (Clinical and Laboratory Study)

I) Patients:

The present study will be carried on periodontitis patients. The patients will be informed about the treatment steps. This includes the possible effects or risks, and other treatment options according to the rules of the Ethical Committee of Faculty of dentistry, Mansoura University.

Groups:

Group I (negative control): 15 periodontally healthy subjects. Group II (positive control): 15 patients will be treated with mechanical debridement only.

Group III (study group A): 15 patients will be treated with mechanical debridement followed by delivery of sunflower seed oil gel for each pocket. (J MAC BOTANICALS, organic cold pressed helianthus annuus sunflower seed oil, Waterglider LLC. Spokane Valley, WA 99216, USA).

Group IV (study group B): 15 patients will be treated with mechanical debridement followed by delivery of ozonated sunflower seed oil gel for each pocket.( PurO3, Ozonated Sunflower Oil combines organic sunflower oil and ozone, giving you an oxygen-rich, soothing gel with high amounts of ozone, 1220 S Happy Hollow Rd Fayetteville, AR 72701, USA).

Periodontal evaluation will be performed for all patients at baseline and after three months including the following parameters:

  • Plaque index (PI).(15)
  • Gingival index.(16)
  • Probing pocket depth (PPD).(17)
  • Clinical attachment level (CAL).(18) B) Gingival crevicular fluid sampling. C) Local drug delivery Adequate amount of prepared ozonated sunflower and sunflower oil gel will be delivered into the selected periodontal pockets.

B) Immunological analysis of TNF-α in GCF

Visão geral do estudo

Status

Concluído

Condições

Intervenção / Tratamento

Descrição detalhada

I) Patients:

The present study will be carried on periodontitis patients. The patient will be selected from Out Patient Clinic, Department of Oral Medicine, Periodontology, Diagnosis and Oral Radiology, Faculty of Dentistry, Mansoura University. The patients will be informed about the treatment steps. This includes the possible effects or risks, and other treatment options according to the rules of the Ethical Committee of Faculty of dentistry, Mansoura University. The patients must be legally competent to provide written consent before performing any required steps.

A)Inclusion Criteria

  1. Patients with Stage II Periodontitis grade B periodontitis (horizontal bone loss with maximum probing depth ≤ 5 mm and with 3-4 mm clinical attachment loss).
  2. Minimum of 20 remaining teeth.
  3. Age range (25 - 50) years.
  4. Good compliance with the plaque control instructions following initial therapy.
  5. Availability for follow up and maintenance program. B) Exclusion Criteria

1. Systemic diseases / drugs which could influence the outcome of the therapy (According to Cornell Medical Index-Health Questionnaire).

2. Receiving periodontal therapy in past 6 month. 3. Pregnant and lactating females. 4. Vulnerable groups of patients (e.g handicapped patients and decisionally impaired individuals).

5. Smoking.

D) Groups:

Group I (negative control): 15 periodontally healthy subjects. Group II (positive control): 15 patients will be treated with mechanical debridement only.

Group III (study group A): 15 patients will be treated with mechanical debridement followed by delivery of sunflower seed oil gel for each pocket. (J MAC BOTANICALS, organic cold pressed helianthus annuus sunflower seed oil, Waterglider LLC. Spokane Valley, WA 99216, USA).

Group IV (study group B): 15 patients will be treated with mechanical debridement followed by delivery of ozonated sunflower seed oil gel for each pocket.( PurO3, Ozonated Sunflower Oil combines organic sunflower oil and ozone, giving you an oxygen-rich, soothing gel with high amounts of ozone, 1220 S Happy Hollow Rd Fayetteville, AR 72701, USA).

II) Clinical Procedures:

  • Medical and dental histories will be taken from patients.
  • Mechanical debridement will be performed using suitable ultrasonic and hand instruments for positive control and study groups.

A) Periodontal assessment:

Periodontal evaluation will be performed for all patients at baseline and after three months including the following parameters:

  • Plaque index (PI).(15)
  • Gingival index.(16)
  • Probing pocket depth (PPD).(17)
  • Clinical attachment level (CAL).(18)

B) Gingival crevicular fluid sampling. The GCF samples will be collected from all subjects at baseline and three months after treatment.(19)

C) Local drug delivery Adequate amount of prepared ozonated sunflower and sunflower oil gel will be delivered into the selected periodontal pockets.

III) Laboratory procedures

A) Pharmaceutics Section: Formulation development:

  1. Sunflower oil and derevatives:

    The study will involve using sunflower oil as pure form and/or ozonated using controlled conditions. The oils will be used in preparation of gel formulation for applications in the mouth cavity using different formulation techniques.

  2. Development of Formulations:

Based on the oil formulation, various gels will be developed with a focus on creating formulations suitable for clinical application.

  • Different gel bases will be evaluated to optimize their physicochemical characteristics.
  • Physicochemical Parameters of the gel formulations will be assessed to ensure the desired properties.
  • The developed gels will undergo in-vitro testing under different conditions.
  • Once optimized, the selected gel formulation(s) will be prepared for testing in clinical trials.

B) Immunological analysis of TNF-α in GCF

Assessment of crevicular fluid TNF-α will be performed using enzyme-linked immunosorbent assay technique

Tipo de estudo

Intervencional

Inscrição (Real)

60

Estágio

  • Fase inicial 1

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Locais de estudo

      • Al Mansurah, Egito
        • Mansoura University, faculty of dentistry

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

  • Adulto

Aceita Voluntários Saudáveis

Sim

Descrição

Inclusion Criteria:

  1. Patients with Stage II Periodontitis grade B periodontitis (horizontal bone loss with maximum probing depth ≤ 5 mm and with 3-4 mm clinical attachment loss).
  2. Minimum of 20 remaining teeth.
  3. Age range (25 - 50) years.
  4. Good compliance with the plaque control instructions following initial therapy.
  5. Availability for follow up and maintenance program.

Exclusion Criteria:

  1. Systemic diseases / drugs which could influence the outcome of the therapy (According to Cornell Medical Index-Health Questionnaire).
  2. Receiving periodontal therapy in past 6 month.
  3. Pregnant and lactating females.
  4. Vulnerable groups of patients (e.g handicapped patients and decisionally impaired individuals).
  5. Smoking.

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Tratamento
  • Alocação: Randomizado
  • Modelo Intervencional: Atribuição Paralela
  • Mascaramento: Dobro

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Outro: positive control group
control recived mechanical debridment only
mechanical debridment
Sem intervenção: negative control
healthy
Experimental: study group A
sunflower seed oil gel for each pocket
patients will be treated with mechanical debridement followed by delivery of sunflower seed oil gel for each pocket
Experimental: study group B
Ozonated Sunflower Oil
patients will be treated with mechanical debridement followed by delivery of ozonated sunflower seed oil gel for each pocket

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
assess the clinical effectiveness of the locally delivered ozonated sunflower seed oil as an adjunctive therapy to mechanical debridement in stage II grade B periodontitis
Prazo: 3 month
1) Plaque Index: deposits were recorded the level of oral hygiene.The percentage of all tooth surfaces that showed the presence of plaque was determined by recording the full-mouth plaque score dichotomously (presence/absence of plaque) on six different points per tooth.The frequency of positive surfaces was given in percentages relative to the total number of tested surfaces. 2) Gingival index: 0 = Normal gingiva.1=Slight inflammation.2 = Moderate glazing. 3 = Severe. 3) Probing pocket depth:For each group, the PPD was measured from the base of the pocket on the whole mouth to the free gingival margin.4) Clinical attachment level:It is the space between the base of the periodontal pocket and CEJ. Six locations were used to measure the clinical attachment loss: three on the facial surface and three on the lingual or palatal surface.5) Bleeding on probing:take the percentage from all teeth that appear BOP
3 month

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
assess the impact of the locally delivered ozonated sunflower seed oil as an adjunctive therapy to mechanical debridement on the GCF level of TNF-α in stage II periodontitis
Prazo: 3 months
GCF sample will be assessed for TNF-α. TNF-α. is an inflammatory mediator. Assessment of gingival crevicular fluid(GCF) TNF-α will be performed using enzyme-linked immunosorbent assay technique.
3 months

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Patrocinador

Investigadores

  • Investigador principal: Ahmed Hashem Alshareef, Bachelors degree, Mansoura University

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Real)

7 de março de 2025

Conclusão Primária (Real)

25 de março de 2026

Conclusão do estudo (Real)

30 de abril de 2026

Datas de inscrição no estudo

Enviado pela primeira vez

30 de maio de 2026

Enviado pela primeira vez que atendeu aos critérios de CQ

7 de junho de 2026

Primeira postagem (Real)

9 de junho de 2026

Atualizações de registro de estudo

Última Atualização Postada (Real)

9 de junho de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

7 de junho de 2026

Última verificação

1 de março de 2025

Mais Informações

Termos relacionados a este estudo

Outros números de identificação do estudo

  • M04020250M

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

SIM

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .